| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9533 |
| Human Intestinal Absorption | HIA+ | 0.9249 |
| Caco-2 Permeability | Caco2- | 0.5221 |
| P-glycoprotein Substrate | Non-substrate | 0.8249 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6201 |
| Non-inhibitor | 0.9259 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9505 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7696 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8254 |
| CYP450 2D6 Substrate | Non-substrate | 0.8305 |
| CYP450 3A4 Substrate | Substrate | 0.5688 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8048 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8037 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9281 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7479 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8067 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9285 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9517 |
| Non-inhibitor | 0.9441 |
| AMES Toxicity | AMES toxic | 0.8143 |
| Carcinogens | Carcinogens | 0.6839 |
| Fish Toxicity | Low FHMT | 0.5587 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6365 |
| Honey Bee Toxicity | High HBT | 0.8798 |
| Biodegradation | Ready biodegradable | 0.7555 |
| Acute Oral Toxicity | I | 0.7735 |
| Carcinogenicity (Three-class) | Non-required | 0.4990 |